Clinical Trial

Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Knee Degenerative Osteoarthritis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 2, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Among knee degenerative osteoarthritis patients aged 50 or older, it will prove the therapeutic effect and safety of Nexsphere-F embolization for patients who need additional treatment because pain is not controlled even if conventional treatments are taken.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-06-20; most recent amendment 2025-03-27.
Status change: Not Yet Recruiting → Recruiting 2023-11-20
Trial Details
NCT Number NCT05917028
Lead Sponsor Next Biomedical Co., Ltd.
Conditions Osteoarthritis
Enrollment 20 participants
Start Date 2023-10-23
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-02